NCT05980923

Brief Summary

Patients admitted to the hospital with acute illness may have a wide spectrum of thyroid function abnormalities. It is largely unknown whether such aberrations are temporary or persist for a long time, and whether they impact prognosis of such patients.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 8, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

October 15, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2025

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2025

Completed
Last Updated

February 25, 2025

Status Verified

February 1, 2025

Enrollment Period

1.3 years

First QC Date

July 20, 2023

Last Update Submit

February 23, 2025

Conditions

Keywords

Thyroid abnormalitiesAcute illnessPrognosisMiddle east

Outcome Measures

Primary Outcomes (1)

  • In hospital mortality

    All-cause death rate in patients with abnormal thyroid function compared with death in those with no abnormal thyroid function during the patients hospital stay..

    From time of study entry until the date of death from any cause, assessed up to 2 weeks.

Secondary Outcomes (1)

  • 6-month mortality rate

    From date of study entry until the date of death from any cause, assessed up to two weeks.

Study Arms (2)

GROUP 1: Acute illness and abnormal thyroid function

Patients admitted to the hospital with acute illness and found to have thyroid function abnormalities.

Other: Performing blood thyroid test (TSH, FT4, FT3)

GROUP 2: Acute illness and normal thyroid function

Patients admitted to the hospital with acute illness and found to have normal thyroid function.

Other: Performing blood thyroid test (TSH, FT4, FT3)

Interventions

Blood test as above

GROUP 1: Acute illness and abnormal thyroid functionGROUP 2: Acute illness and normal thyroid function

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

nclusion Criteria: All patients admitted to the hospital with acute illness will have their serum level of thyroid stimulating hormone and free T4 and T3 measured on admission. Clinical and laboratory profiles of patients with abnormal thyroid function (Group 1) will be compared to those with normal thyroid function (Group 2). Serum thyroid test will be repeated at 6 months. Short and long term survival of both groups will be compared as well. Diagnosis on admission is acute illness includes: heart failure, acute coronary syndrome, sepsis, acute stroke, hypotension, acute system-organ failure including renal and hepatic failure.

You may qualify if:

  • Hospital admission
  • Adults aged 18 years and above
  • Willing to sign an informed consent
  • Diagnosis on admission is acute illness that includes: heart failure, acute coronary syndrome, sepsis, acute stroke, hypotension, acute system-organ failure including renal and hepatic failure.

You may not qualify if:

  • Age less than 18 years.
  • Refusal to sign consent.
  • Admission for a reason not classified as acute illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istishari Hospital

Amman, 11888, Jordan

Location

MeSH Terms

Conditions

Thyroid Diseases

Interventions

Thyrotropin

Condition Hierarchy (Ancestors)

Endocrine System Diseases

Intervention Hierarchy (Ancestors)

Pituitary Hormones, AnteriorPituitary HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPeptidesAmino Acids, Peptides, and Proteins
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2023

First Posted

August 8, 2023

Study Start

October 15, 2023

Primary Completion

January 15, 2025

Study Completion

January 30, 2025

Last Updated

February 25, 2025

Record last verified: 2025-02

Locations